Sectors With The Most Picks
Biotechnology
| Outperform | |||
|---|---|---|---|
| Ticker | Company Name | Pick Date | Score |
| View all Tickers in Tag | |||
| ARNA | Arena Pharmaceuticals, Inc. | 9/23/2011 | +386.18 |
| ANDS.DL | Anadys Pharmaceuticals, Inc. | 4/19/2011 | +248.25 |
| THLD | Threshold Pharmaceuticals, Inc. | 5/19/2011 | +175.82 |
| IDIX | Idenix Pharmaceuticals, Inc. | 12/2/2009 | +156.04 |
| ITMN | InterMune, Inc. | 10/29/2010 | +147.59 |
| FOLD | Amicus Therapeutics, Inc. | 11/9/2011 | +106.97 |
| ANTH | Anthera Pharmaceuticals Inc | 9/16/2010 | +100.74 |
| ANAC | Anacor Pharmaceuticals | 2/28/2013 | +90.53 |
| REGN | Regeneron Pharmaceuticals, Inc. | 11/14/2011 | +71.57 |
| ENDP | Endo Health Solutions, Inc. | 1/11/2010 | +71.36 |
| TSPT | Transcept Pharmaceuticals | 7/18/2011 | +70.86 |
| ANTH | Anthera Pharmaceuticals Inc | 7/2/2012 | +68.79 |
| ALNY | Alnylam Pharmaceuticals, Inc. | 7/11/2012 | +64.04 |
| MITI | Micromet, Inc. | 4/28/2011 | +62.24 |
| AFFY | Affymax, Inc. | 12/31/2010 | +54.46 |
| FURX | Furiex Pharmaceuticals, Inc. | 1/4/2013 | +54.31 |
| VPHM | ViroPharma, Inc. | 8/31/2009 | +50.76 |
| GNOM | Complete Genomics | 5/15/2012 | +49.92 |
| CLDX | Celldex Therapeutics, Inc. | 1/28/2013 | +46.75 |
| ISIS | ISIS Pharmaceuticals, Inc. | 1/10/2013 | +46.13 |
| CYTK | Cytokinetics Inc | 8/17/2012 | +40.81 |
| THRX | Theravance, Inc. | 11/9/2012 | +40.66 |
| FOLD | Amicus Therapeutics, Inc. | 7/7/2010 | +38.74 |
| NGSXE | NeurogesX, Inc. | 6/22/2011 | +38.53 |
| ALKS | Alkermes, Inc. | 1/8/2013 | +36.93 |
| EXEL | Exelixis, Inc. | 7/27/2010 | +35.55 |
| MAXY | Maxygen, Inc. | 12/15/2010 | +33.62 |
| SRPT | Sarepta Therapeutics | 8/9/2012 | +32.34 |
| KERX | Keryx Biopharmaceuticals | 12/18/2012 | +31.89 |
| ITMN | InterMune, Inc. | 5/5/2010 | +30.26 |
| ELN | Elan Corp, plc (ADR) | 1/12/2010 | +28.28 |
| PTIE | Pain Therapeutics, Inc. | 6/27/2011 | +28.18 |
| APPA | A.P. Pharma, Inc. | 12/31/2012 | +27.50 |
| TLON | Talon Therapeutics | 4/3/2012 | +27.29 |
| SNTA | Synta Pharmaceuticals Corp. | 8/13/2010 | +27.04 |
| LGND | Ligand Pharmaceuticals, Inc. | 5/5/2011 | +26.99 |
| VPHM | ViroPharma, Inc. | 8/6/2012 | +26.85 |
| ARRY | Array BioPharma, Inc. | 11/1/2012 | +26.83 |
| ARNA | Arena Pharmaceuticals, Inc. | 4/8/2011 | +26.67 |
| QCOR | Questcor Pharmaceuticals | 9/19/2012 | +25.98 |
| OREX | Orexigen Therapeutics, Inc. | 6/6/2011 | +25.75 |
| PIP | PharmAthene, Inc. | 1/10/2013 | +25.59 |
| RHHBY | Roche Holding Ltd. (ADR) | 11/29/2010 | +25.42 |
| ACHN | Achillion Pharmaceuticals, Inc. | 8/16/2012 | +24.21 |
| PATH | NuPathe | 8/4/2011 | +23.79 |
| SLXP | Salix Pharmaceuticals, Ltd. | 4/19/2011 | +23.24 |
| ASTM | Aastrom Biosciences Inc | 12/30/2010 | +23.03 |
| BMRN | BioMarin Pharmaceutical, Inc. | 10/23/2012 | +23.03 |
| PCYC | Pharmacyclics, Inc. | 9/5/2012 | +22.88 |
| CLSN | Celsion Corp | 10/4/2012 | +22.73 |
| ONXX | Onyx Pharmaceuticals, Inc. | 4/18/2011 | +22.01 |
| VICL | Vical, Inc. | 10/13/2010 | +21.98 |
| GNOM | Complete Genomics | 6/21/2012 | +21.96 |
| SQNM | Sequenom, Inc. | 12/7/2009 | +21.91 |
| NAVB | Navidea Biopharmaceuticals, Inc. | 6/15/2011 | +21.72 |
| ALNY | Alnylam Pharmaceuticals, Inc. | 4/19/2012 | +21.53 |
| EXAS | EXACT Sciences Corp | 12/21/2011 | +21.25 |
| ECYT | Endocyte, Inc. | 12/21/2012 | +21.09 |
| TSRX | Trius Therapeutics, Inc. | 11/10/2010 | +20.74 |
| MYGN | Myriad Genetics, Inc. | 2/8/2013 | +20.72 |
| TSRX | Trius Therapeutics, Inc. | 11/30/2012 | +20.40 |
| SVNT | Savient Pharmaceuticals Inc | 6/21/2012 | +20.35 |
| ARQL | ArQule, Inc. | 9/7/2011 | +20.08 |
| BNVIQ | Bionovo Inc | 2/2/2011 | +19.76 |
| KERX | Keryx Biopharmaceuticals | 1/4/2012 | +19.02 |
| ACAD | ACADIA Pharmaceuticals, Inc. | 8/14/2012 | +19.00 |
| XNPT | XenoPort, Inc. | 3/21/2011 | +18.72 |
| XNPT | XenoPort, Inc. | 7/14/2010 | +18.61 |
| VNDA | Vanda Pharmaceuticals, Inc. | 11/9/2012 | +18.33 |
| THRX | Theravance, Inc. | 8/26/2009 | +18.31 |
| SGMO | Sangamo Biosciences, Inc. | 11/7/2012 | +17.69 |
| PBTH | PROLOR Biotech, Inc. | 6/13/2011 | +17.49 |
| ANTH | Anthera Pharmaceuticals Inc | 2/7/2011 | +17.25 |
| CLDX | Celldex Therapeutics, Inc. | 5/15/2012 | +17.13 |
| CYTK | Cytokinetics Inc | 8/9/2012 | +16.84 |
| KERX | Keryx Biopharmaceuticals | 4/3/2012 | +16.82 |
| CCXI | ChemoCentryx, Inc. | 12/12/2012 | +16.79 |
| SRPT | Sarepta Therapeutics | 4/26/2013 | +16.73 |
| SGMO | Sangamo Biosciences, Inc. | 2/7/2013 | +16.39 |
| INCY | Incyte Corp | 11/26/2012 | +16.13 |
| VRTX | Vertex Pharmaceuticals, Inc. | 11/21/2011 | +16.11 |
| CYTR | Cytrx Corp | 4/26/2011 | +16.04 |
| ARNA | Arena Pharmaceuticals, Inc. | 8/4/2011 | +16.01 |
| CRME | Cardiome Pharma Corp | 3/29/2011 | +15.92 |
| GILD | Gilead Sciences, Inc. | 7/31/2012 | +15.84 |
| VRTX | Vertex Pharmaceuticals, Inc. | 4/25/2011 | +15.82 |
| ASTX | Astex Pharmaceuticals, Inc. | 2/10/2012 | +15.41 |
| CRIS | Curis, Inc. | 3/25/2013 | +15.29 |
| DSCO | Discovery Laboratories, Inc. | 8/4/2011 | +15.20 |
| ECYT | Endocyte, Inc. | 4/30/2012 | +14.76 |
| PACB | Pacific Biosciences of California, Inc. | 1/3/2012 | +14.58 |
| ITMN | InterMune, Inc. | 4/30/2012 | +14.50 |
| REGN | Regeneron Pharmaceuticals, Inc. | 8/3/2011 | +14.49 |
| CLSN | Celsion Corp | 2/25/2011 | +14.19 |
| SQNM | Sequenom, Inc. | 8/11/2010 | +14.09 |
| DSCO | Discovery Laboratories, Inc. | 6/8/2011 | +14.06 |
| QCOR | Questcor Pharmaceuticals | 1/4/2013 | +13.92 |
| CELG | Celgene Corp | 12/6/2010 | +13.84 |
| SGMO | Sangamo Biosciences, Inc. | 2/15/2012 | +13.63 |
| PYMXQ | Polymedix Inc | 5/6/2011 | +13.56 |
| ALNY | Alnylam Pharmaceuticals, Inc. | 5/3/2011 | +13.47 |
| GALE | Galena Biopharma, Inc. | 9/27/2011 | +13.33 |
| PATH | NuPathe | 11/26/2012 | +13.10 |
| ASTX | Astex Pharmaceuticals, Inc. | 11/1/2012 | +13.03 |
| DEPO | DepoMed, Inc. | 5/7/2012 | +12.89 |
| AFFX | Affymetrix, Inc. | 1/11/2011 | +12.87 |
| ROSG | Rosetta Genomics Ltd. (USA) | 8/23/2012 | +12.78 |
| REGN | Regeneron Pharmaceuticals, Inc. | 5/4/2011 | +12.78 |
| ROSG | Rosetta Genomics Ltd. (USA) | 11/5/2012 | +12.71 |
| CCXI | ChemoCentryx, Inc. | 4/19/2013 | +12.53 |
| TZYM | Tranzyme, Inc. | 1/30/2013 | +12.43 |
| GILD | Gilead Sciences, Inc. | 3/16/2012 | +12.41 |
| CRIS | Curis, Inc. | 9/23/2010 | +12.30 |
| DNDN | Dendreon Corp | 11/5/2012 | +12.20 |
| ALKS | Alkermes, Inc. | 3/30/2011 | +11.92 |
| CLDX | Celldex Therapeutics, Inc. | 12/5/2012 | +11.92 |
| ARWR | Arrowhead Research Corp | 4/19/2013 | +11.88 |
| DSCO | Discovery Laboratories, Inc. | 4/19/2011 | +11.83 |
| INFI | Infinity Pharmaceuticals, Inc. | 11/5/2012 | +11.77 |
| TSRX | Trius Therapeutics, Inc. | 12/13/2010 | +11.66 |
| ARQL | ArQule, Inc. | 3/14/2012 | +11.64 |
| RIGL | Rigel Pharmaceuticals, Inc. | 12/13/2012 | +11.49 |
| SRPT | Sarepta Therapeutics | 10/3/2012 | +11.45 |
| ASTX | Astex Pharmaceuticals, Inc. | 4/25/2011 | +11.37 |
| THRX | Theravance, Inc. | 1/9/2012 | +11.35 |
| GALE | Galena Biopharma, Inc. | 9/10/2012 | +11.33 |
| BMRN | BioMarin Pharmaceutical, Inc. | 11/15/2011 | +11.32 |
| CERS | Cerus Corp | 1/13/2011 | +11.32 |
| BPAX | Biosante Pharmaceuticals Inc | 12/19/2012 | +11.30 |
| SQNM | Sequenom, Inc. | 2/22/2011 | +11.18 |
| ARRY | Array BioPharma, Inc. | 4/19/2011 | +11.04 |
| AEZS | Aeterna Zentaris Inc | 10/5/2012 | +11.03 |
| PATH | NuPathe | 12/12/2012 | +10.96 |
| BCRX | BioCryst Pharmaceuticals, Inc. | 3/15/2011 | +10.95 |
| ASTX | Astex Pharmaceuticals, Inc. | 11/28/2012 | +10.76 |
| VVUS | VIVUS, Inc. | 11/6/2012 | +10.61 |
| EXAS | EXACT Sciences Corp | 10/29/2010 | +10.58 |
| PDLI | PDL BioPharma, Inc. | 1/18/2011 | +10.47 |
| TRGT | Targacept , Inc. | 2/14/2012 | +10.28 |
| INSM | Insmed, Inc. | 1/26/2011 | +10.28 |
| DNDN | Dendreon Corp | 12/21/2012 | +10.27 |
| ACAD | ACADIA Pharmaceuticals, Inc. | 11/27/2012 | +10.04 |
| CRME | Cardiome Pharma Corp | 9/8/2009 | +9.96 |
| ARIA | Ariad Pharmaceuticals, Inc. | 5/15/2012 | +9.92 |
| VRTX | Vertex Pharmaceuticals, Inc. | 11/2/2012 | +9.83 |
| ARWR | Arrowhead Research Corp | 1/28/2013 | +9.79 |
| SCLN | SciClone Pharmaceuticals, Inc. | 1/7/2011 | +9.68 |
| NPSP | NPS Pharmaceuticals, Inc. | 12/12/2012 | +9.68 |
| PGNX | Progenics Pharmaceuticals, Inc. | 8/7/2012 | +9.65 |
| CYTK | Cytokinetics Inc | 7/5/2012 | +9.63 |
| CCXI | ChemoCentryx, Inc. | 9/12/2012 | +9.61 |
| SRPT | Sarepta Therapeutics | 9/13/2012 | +9.43 |
| AVNR | AVANIR Pharmaceuticals | 5/3/2011 | +9.38 |
| ALXN | Alexion Pharmaceuticals, Inc. | 11/15/2011 | +9.22 |
| GALE | Galena Biopharma, Inc. | 3/1/2011 | +9.21 |
| SCMP | Sucampo Pharmaceuticals, Inc. | 1/28/2013 | +9.19 |
| VRTX | Vertex Pharmaceuticals, Inc. | 8/11/2010 | +9.12 |
| SGEN | Seattle Genetics, Inc. | 11/4/2011 | +9.09 |
| BMRN | BioMarin Pharmaceutical, Inc. | 1/7/2013 | +8.90 |
| EBS | Emergent BioSolutions, Inc. | 5/19/2011 | +8.83 |
| GALE | Galena Biopharma, Inc. | 8/17/2012 | +8.71 |
| GALE | Galena Biopharma, Inc. | 4/26/2011 | +8.65 |
| CELG | Celgene Corp | 1/8/2013 | +8.59 |
| CRTX | Cornerstone Therapeutics Inc. | 12/3/2010 | +8.59 |
| CPHD | Cepheid | 7/30/2012 | +8.46 |
| ALKS | Alkermes, Inc. | 7/2/2012 | +8.45 |
| BMRN | BioMarin Pharmaceutical, Inc. | 9/20/2012 | +8.44 |
| DEPO | DepoMed, Inc. | 10/10/2011 | +8.37 |
| INCY | Incyte Corp | 10/12/2011 | +8.36 |
| GALE | Galena Biopharma, Inc. | 5/1/2012 | +8.30 |
| SIGA | SIGA Technologies, Inc. | 11/8/2010 | +8.20 |
| GNOM | Complete Genomics | 8/6/2012 | +8.16 |
| SNTS | Santarus, Inc. | 4/8/2011 | +8.10 |
| VNDA | Vanda Pharmaceuticals, Inc. | 12/21/2012 | +8.10 |
| SLXP | Salix Pharmaceuticals, Ltd. | 12/12/2012 | +8.01 |
| ALNY | Alnylam Pharmaceuticals, Inc. | 2/14/2012 | +7.99 |
| VVUS | VIVUS, Inc. | 7/19/2010 | +7.90 |
| ARQL | ArQule, Inc. | 8/29/2012 | +7.89 |
| INCY | Incyte Corp | 11/1/2012 | +7.85 |
| ZIOP | ZIOPHARM Oncology | 3/17/2011 | +7.85 |
| MDVN | Medivation, Inc. | 3/5/2013 | +7.80 |
| GALE | Galena Biopharma, Inc. | 3/6/2012 | +7.79 |
| TKMR | Tekmira Pharmaceuticals | 3/25/2011 | +7.77 |
| SVNT | Savient Pharmaceuticals Inc | 8/17/2012 | +7.72 |
| ONTY | Oncothyreon, Inc. | 3/6/2012 | +7.71 |
| OPK | Opko Health, Inc. | 12/27/2012 | +7.67 |
| CDXS | Codexis Inc Com | 10/12/2011 | +7.46 |
| VICL | Vical, Inc. | 2/10/2012 | +7.45 |
| PTIE | Pain Therapeutics, Inc. | 12/20/2012 | +7.35 |
| SGMO | Sangamo Biosciences, Inc. | 12/18/2012 | +7.25 |
| PDLI | PDL BioPharma, Inc. | 8/20/2012 | +7.23 |
| ECYT | Endocyte, Inc. | 4/28/2011 | +7.22 |
| ALXN | Alexion Pharmaceuticals, Inc. | 9/5/2012 | +7.14 |
| IMGN | ImmunoGen, Inc. | 4/15/2013 | +7.13 |
| VVUS | VIVUS, Inc. | 4/11/2011 | +7.11 |
| MDT | Medtronic, Inc. | 10/15/2010 | +7.10 |
| PATH | NuPathe | 12/27/2012 | +7.03 |
| LIFE | Life Technologies Corporation | 6/2/2011 | +7.01 |
| CELG | Celgene Corp | 7/5/2012 | +6.79 |
| GILD | Gilead Sciences, Inc. | 4/26/2010 | +6.79 |
| CHTP | Chelsea Therapeutics International Ltd. | 3/4/2011 | +6.78 |
| MNKD | MannKind Corp | 2/11/2011 | +6.78 |
| INSM | Insmed, Inc. | 8/2/2011 | +6.61 |
| IDRA | Idera Pharmaceuticals, Inc. | 7/9/2010 | +6.58 |
| KERX | Keryx Biopharmaceuticals | 7/11/2012 | +6.56 |
| INO | Inovio Biomedical Corp. | 3/21/2013 | +6.51 |
| IMGN | ImmunoGen, Inc. | 2/5/2013 | +6.50 |
| ABBV | AbbVie Inc. | 1/3/2013 | +6.44 |
| ISIS | ISIS Pharmaceuticals, Inc. | 12/22/2009 | +6.26 |
| VRTX | Vertex Pharmaceuticals, Inc. | 5/9/2012 | +6.24 |
| AEZS | Aeterna Zentaris Inc | 1/9/2012 | +6.21 |
| OSIR | Osiris Therapeutics, Inc. | 4/11/2011 | +6.16 |
| ASTX | Astex Pharmaceuticals, Inc. | 8/17/2012 | +6.02 |
| MYGN | Myriad Genetics, Inc. | 4/8/2011 | +5.93 |
| PBTH | PROLOR Biotech, Inc. | 2/13/2013 | +5.83 |
| DNDN | Dendreon Corp | 8/4/2011 | +5.82 |
| ALNY | Alnylam Pharmaceuticals, Inc. | 8/13/2012 | +5.80 |
| ISIS | ISIS Pharmaceuticals, Inc. | 11/5/2012 | +5.72 |
| NPSP | NPS Pharmaceuticals, Inc. | 10/18/2012 | +5.70 |
| DARA | Dara Biosciences Inc | 11/5/2012 | +5.66 |
| GHDX | Genomic Health, Inc. | 6/23/2011 | +5.40 |
| NVS | Novartis AG (ADR) | 8/5/2010 | +4.45 |
| SIGA | SIGA Technologies, Inc. | 1/28/2010 | +4.29 |
| LXRX | Lexicon Pharmaceuticals, Inc. | 4/23/2010 | +3.98 |
| RPTP | Raptor Pharmaceuticals Corp. | 12/18/2012 | +3.68 |
| MDT | Medtronic, Inc. | 8/11/2009 | +3.62 |
| AEZS | Aeterna Zentaris Inc | 3/27/2013 | +3.53 |
| ROSG | Rosetta Genomics Ltd. (USA) | 11/29/2012 | +3.10 |
| CBST | Cubist Pharmaceuticals, Inc. | 5/21/2013 | +2.38 |
| CBST | Cubist Pharmaceuticals, Inc. | 9/22/2009 | +1.91 |
| TKMR | Tekmira Pharmaceuticals | 3/18/2013 | +1.46 |
| IMMU | Immunomedics, Inc. | 1/28/2013 | +0.90 |
| XOMA | XOMA Limited | 9/5/2012 | -0.15 |
| PBTH | PROLOR Biotech, Inc. | 4/30/2013 | -1.43 |
| SNSS | Sunesis Pharmaceuticals, Inc. | 12/30/2010 | -2.44 |
| VPHM | ViroPharma, Inc. | 3/18/2013 | -3.48 |
| PDLI | PDL BioPharma, Inc. | 12/5/2012 | -4.39 |
| PATH | NuPathe | 5/16/2013 | -4.53 |
| SCMP | Sucampo Pharmaceuticals, Inc. | 5/20/2013 | -5.02 |
| JAZZ | Jazz Pharmaceuticals, Inc. | 1/8/2013 | -7.22 |
| ZIOP | ZIOPHARM Oncology | 4/26/2013 | -9.33 |
| IMUC | ImmunoCellular Therapeutics, Ltd. | 2/7/2013 | -9.90 |
| ALXN | Alexion Pharmaceuticals, Inc. | 12/4/2012 | -10.65 |
| CLDX | Celldex Therapeutics, Inc. | 4/26/2013 | -11.93 |
| OREX | Orexigen Therapeutics, Inc. | 1/8/2013 | -11.93 |
| SCLN | SciClone Pharmaceuticals, Inc. | 11/20/2012 | -12.53 |
| RIGL | Rigel Pharmaceuticals, Inc. | 4/5/2013 | -14.99 |
| DYAX | Dyax Corp. | 4/26/2013 | -16.06 |
| TRGT | Targacept , Inc. | 3/20/2012 | -17.74 |
| DEPO | DepoMed, Inc. | 2/25/2013 | -19.12 |
| PACB | Pacific Biosciences of California, Inc. | 5/9/2012 | -20.30 |
| SGMO | Sangamo Biosciences, Inc. | 3/15/2013 | -20.43 |
| VICL | Vical, Inc. | 7/2/2012 | -23.06 |
| EXAS | EXACT Sciences Corp | 1/8/2013 | -23.68 |
| ELN | Elan Corp, plc (ADR) | 7/24/2012 | -23.91 |
| CBRX | Columbia Labs Inc | 10/26/2012 | -25.47 |
| ILMN | Illumina Inc | 5/17/2011 | -26.28 |
| APPY | Venaxis, Inc. | 3/28/2013 | -30.41 |
| TELK | Telik Inc | 1/30/2013 | -30.77 |
| ABIO | Arca Biopharma Inc | 3/14/2013 | -31.50 |
| ITMN | InterMune, Inc. | 7/16/2012 | -36.90 |
| SQNM | Sequenom, Inc. | 8/14/2009 | -37.43 |
| ARIA | Ariad Pharmaceuticals, Inc. | 10/19/2012 | -39.38 |
| CRME | Cardiome Pharma Corp | 5/10/2012 | -40.62 |
| IDRA | Idera Pharmaceuticals, Inc. | 10/19/2010 | -40.93 |
| NGSXE | NeurogesX, Inc. | 2/24/2011 | -42.20 |
| HALO | Halozyme Therapeutics, Inc. | 7/27/2012 | -42.49 |
| APPA | A.P. Pharma, Inc. | 3/13/2013 | -42.65 |
| CHBT | China Biotics Inc | 8/16/2010 | -42.95 |
| QGEN | QIAGEN N.V. | 11/22/2010 | -43.19 |
| ANDS.DL | Anadys Pharmaceuticals, Inc. | 10/18/2010 | -44.09 |
| CRME | Cardiome Pharma Corp | 9/3/2010 | -44.71 |
| SVNT | Savient Pharmaceuticals Inc | 1/18/2013 | -45.61 |
| KERX | Keryx Biopharmaceuticals | 5/13/2010 | -45.63 |
| SIGA | SIGA Technologies, Inc. | 7/25/2011 | -45.89 |
| BVTIQ | Biovest Intl Inc | 1/7/2011 | -46.71 |
| DARA | Dara Biosciences Inc | 2/1/2013 | -47.73 |
| IDIX | Idenix Pharmaceuticals, Inc. | 8/16/2012 | -50.23 |
| DSCO | Discovery Laboratories, Inc. | 12/30/2010 | -50.60 |
| AFFY | Affymax, Inc. | 3/13/2013 | -51.06 |
| SVNT | Savient Pharmaceuticals Inc | 1/14/2011 | -51.70 |
| ALNY | Alnylam Pharmaceuticals, Inc. | 8/16/2010 | -52.98 |
| NAVB | Navidea Biopharmaceuticals, Inc. | 9/4/2012 | -53.05 |
| MSTX | Mast Therapeutics, Inc. | 8/1/2011 | -53.11 |
| BDSI | BioDelivery Sciences International, Inc. | 9/4/2009 | -54.24 |
| FOLD | Amicus Therapeutics, Inc. | 7/25/2012 | -54.86 |
| CYTK | Cytokinetics Inc | 2/18/2011 | -55.04 |
| TSPT | Transcept Pharmaceuticals | 9/27/2012 | -56.44 |
| MRNA | Marina Biotech | 4/15/2011 | -56.55 |
| SQNM | Sequenom, Inc. | 10/11/2011 | -58.68 |
| YONG | Yongye Biotechnology International | 2/22/2011 | -59.79 |
| DSCO | Discovery Laboratories, Inc. | 3/16/2012 | -60.53 |
| DVAX | Dynavax Technologies Corp | 10/17/2012 | -61.10 |
| ARQL | ArQule, Inc. | 9/28/2012 | -61.38 |
| ITMN | InterMune, Inc. | 11/4/2011 | -61.47 |
| IDRA | Idera Pharmaceuticals, Inc. | 5/3/2012 | -61.62 |
| EBS | Emergent BioSolutions, Inc. | 7/5/2011 | -61.86 |
| MYGN | Myriad Genetics, Inc. | 9/18/2009 | -62.01 |
| MRNA | Marina Biotech | 12/10/2010 | -64.37 |
| ANTH | Anthera Pharmaceuticals Inc | 7/31/2012 | -64.51 |
| MYRX | Myriad Pharmaceuticals Inc | 8/13/2010 | -65.30 |
| DNDN | Dendreon Corp | 2/27/2012 | -65.51 |
| TLON | Talon Therapeutics | 8/9/2012 | -65.55 |
| GALE | Galena Biopharma, Inc. | 12/17/2010 | -66.17 |
| GERN | Geron Corp | 12/9/2010 | -66.42 |
| ABPI | Accentia Biopharmaceuticals, Inc. | 2/8/2011 | -67.78 |
| ARNA | Arena Pharmaceuticals, Inc. | 9/15/2010 | -69.90 |
| ANTH | Anthera Pharmaceuticals Inc | 3/12/2012 | -70.55 |
| MNTA | Momenta Pharmaceuticals, Inc. | 8/18/2010 | -73.27 |
| TRGT | Targacept , Inc. | 6/28/2011 | -73.53 |
| ZLCS | Zalicus Inc Com | 9/4/2012 | -75.52 |
| PACB | Pacific Biosciences of California, Inc. | 3/28/2011 | -76.31 |
| MRNA | Marina Biotech | 1/13/2012 | -79.04 |
| CLSN | Celsion Corp | 1/14/2013 | -84.11 |
| EXEL | Exelixis, Inc. | 5/23/2011 | -84.37 |
| CRME | Cardiome Pharma Corp | 6/3/2011 | -91.52 |
| ZIOP | ZIOPHARM Oncology | 6/2/2011 | -92.78 |
| SVNT | Savient Pharmaceuticals Inc | 8/4/2011 | -93.00 |
| AFFY | Affymax, Inc. | 12/10/2012 | -96.34 |
| Underperform | |||
|---|---|---|---|
| Ticker | Company Name | Pick Date | Score |
| View all Tickers in Tag | |||
| PPHM | Peregrine Pharmaceuticals | 9/4/2012 | +57.40 |
| HEB | Hemispherx BioPharma, Inc. | 9/8/2009 | +54.40 |
| NGSXE | NeurogesX, Inc. | 1/31/2012 | +43.69 |
| GTXI | GTx, Inc. | 1/30/2012 | +41.07 |
| PPHM | Peregrine Pharmaceuticals | 8/13/2012 | +35.58 |
| HEB | Hemispherx BioPharma, Inc. | 8/28/2012 | +32.44 |
| ACUR | Acura Pharmaceuticals Inc. | 11/29/2012 | +30.55 |
| PPHM | Peregrine Pharmaceuticals | 9/24/2012 | +29.28 |
| CYTX | Cytori Therapeutics, Inc. (USA) | 12/16/2009 | +27.25 |
| CDXC | CHROMADEX CORPORAT COM STK USD0.001 | 2/17/2012 | +25.36 |
| OXGN | Oxigene Inc | 5/12/2011 | +22.76 |
| OREX | Orexigen Therapeutics, Inc. | 7/17/2012 | +22.28 |
| NNVC | NanoViricides, Inc. | 2/17/2012 | +21.48 |
| ACUR | Acura Pharmaceuticals Inc. | 12/12/2012 | +20.51 |
| ZLCS | Zalicus Inc Com | 6/21/2012 | +19.38 |
| ISCO | International Stem Cell Corp. | 4/8/2010 | +18.27 |
| CDXC | CHROMADEX CORPORAT COM STK USD0.001 | 5/3/2012 | +18.12 |
| GERN | Geron Corp | 9/10/2012 | +17.08 |
| AFFY | Affymax, Inc. | 3/27/2012 | +16.73 |
| ROSG | Rosetta Genomics Ltd. (USA) | 7/3/2012 | +15.77 |
| OSIR | Osiris Therapeutics, Inc. | 6/22/2012 | +15.62 |
| CYCC | Cyclacel Pharmaceuticals Inc | 12/4/2012 | +15.48 |
| ONCY | Oncolytics Biotech, Inc. (USA) | 1/29/2013 | +15.43 |
| CLSN | Celsion Corp | 2/11/2013 | +15.20 |
| CTIC | Cell Therapeutics Inc | 2/15/2013 | +14.83 |
| NVGN | Novogen Limited (ADR) | 2/19/2013 | +14.45 |
| CMXI | Cytomedix Inc | 9/12/2012 | +14.34 |
| PCYC | Pharmacyclics, Inc. | 7/3/2012 | +14.34 |
| NGSXE | NeurogesX, Inc. | 3/14/2012 | +14.20 |
| ONCY | Oncolytics Biotech, Inc. (USA) | 10/5/2010 | +13.67 |
| PCYC | Pharmacyclics, Inc. | 2/8/2010 | +13.45 |
| NVAX | Novavax, Inc. | 7/16/2012 | +13.18 |
| ACHN | Achillion Pharmaceuticals, Inc. | 1/7/2013 | +12.22 |
| NLNK | NewLink Genetics Corporation | 7/5/2012 | +12.02 |
| ONCY | Oncolytics Biotech, Inc. (USA) | 12/17/2012 | +11.99 |
| CTIC | Cell Therapeutics Inc | 3/18/2013 | +11.21 |
| SRPT | Sarepta Therapeutics | 4/16/2013 | +11.07 |
| TTHI | Transition Therapeutics Inc. | 10/1/2009 | +10.22 |
| OREX | Orexigen Therapeutics, Inc. | 2/23/2012 | +10.17 |
| MDGN | Medgenics, Inc. | 8/28/2012 | +9.76 |
| NVGN | Novogen Limited (ADR) | 3/21/2013 | +9.75 |
| SNTA | Synta Pharmaceuticals Corp. | 10/1/2012 | +9.48 |
| PSTI | Pluristem Therapeutics, Inc. | 8/15/2012 | +9.43 |
| VRML | Vermillion, Inc. | 1/19/2010 | +9.33 |
| CTIC | Cell Therapeutics Inc | 1/28/2013 | +9.15 |
| PRAN | Prana Biotechnology Limited (ADR) | 1/9/2013 | +9.01 |
| XNPT | XenoPort, Inc. | 5/20/2013 | +8.64 |
| PSTI | Pluristem Therapeutics, Inc. | 11/26/2012 | +8.58 |
| VVUS | VIVUS, Inc. | 1/8/2013 | +8.46 |
| CTIC | Cell Therapeutics Inc | 1/8/2013 | +8.03 |
| PSTI | Pluristem Therapeutics, Inc. | 1/28/2013 | +7.70 |
| OSIR | Osiris Therapeutics, Inc. | 12/17/2012 | +7.68 |
| PDLI | PDL BioPharma, Inc. | 5/2/2011 | +7.51 |
| VVUS | VIVUS, Inc. | 11/1/2010 | +7.39 |
| VVUS | VIVUS, Inc. | 2/24/2012 | +7.28 |
| BONE | Bacterin International Holdings | 7/20/2012 | +7.12 |
| NNVC | NanoViricides, Inc. | 5/21/2013 | +7.07 |
| PSTI | Pluristem Therapeutics, Inc. | 1/2/2013 | +6.97 |
| CERS | Cerus Corp | 8/1/2012 | +6.86 |
| PLX | Protalix BioTherapeutics, Inc. | 4/30/2012 | +6.78 |
| CMXI | Cytomedix Inc | 8/15/2012 | +6.67 |
| OREX | Orexigen Therapeutics, Inc. | 9/11/2012 | +6.34 |
| PSTI | Pluristem Therapeutics, Inc. | 9/14/2012 | +5.12 |
| TTNP | Titan Pharmaceuticals, Inc. | 5/6/2013 | +2.92 |
| PBTH | PROLOR Biotech, Inc. | 8/11/2010 | +1.96 |
| TRGT | Targacept , Inc. | 10/1/2009 | +1.84 |
| PPHM | Peregrine Pharmaceuticals | 12/6/2012 | -20.56 |
| AFFY | Affymax, Inc. | 5/7/2013 | -22.18 |
| STEM | StemCells, Inc. | 7/17/2012 | -22.76 |
| REGN | Regeneron Pharmaceuticals, Inc. | 3/15/2013 | -43.86 |
| REGN | Regeneron Pharmaceuticals, Inc. | 2/10/2012 | -73.38 |
| KERX | Keryx Biopharmaceuticals | 1/23/2013 | -132.39 |
| MNKD | MannKind Corp | 12/21/2012 | -135.84 |
Pharmaceuticals
132 Outperform
27 Underperform
Dedicated Short Bias Funds
7 Outperform
75 Underperform
Oil, Gas and Consumable Fuels
71 Outperform
7 Underperform
Metals and Mining
49 Outperform
15 Underperform
Commercial Banks
43 Outperform
6 Underperform
Healthcare Equipment and Supplies
39 Outperform
6 Underperform
Semiconductors and Semiconductor Equipment
39 Outperform
0 Underperform
Internet Software and Services
23 Outperform
11 Underperform
Communications Equipment
32 Outperform
2 Underperform
Computers and Peripherals
31 Outperform
1 Underperform
Software
26 Outperform
4 Underperform
Life Sciences Tools and Services
26 Outperform
2 Underperform
Specialty Retail
21 Outperform
5 Underperform
Insurance
25 Outperform
1 Underperform
Household Durables
15 Outperform
9 Underperform
Capital Markets
19 Outperform
4 Underperform
Food Products
15 Outperform
4 Underperform
Diversified Financial Services
18 Outperform
1 Underperform
Diversified Telecommunication Services
16 Outperform
1 Underperform
Marine
15 Outperform
0 Underperform
Textiles, Apparel and Luxury Goods
13 Outperform
2 Underperform
Beverages
12 Outperform
1 Underperform
Chemicals
11 Outperform
2 Underperform
Energy Equipment and Services
11 Outperform
2 Underperform
Specialty/Miscellaneous Funds
5 Outperform
8 Underperform
Internet and Catalog Retail
6 Outperform
6 Underperform
Electronic Equipment, Instruments and Components
11 Outperform
0 Underperform
Thrifts and Mortgage Finance
6 Outperform
5 Underperform
IT Services
9 Outperform
1 Underperform
Commercial Services and Supplies
5 Outperform
2 Underperform
Natural Resources Funds
5 Outperform
1 Underperform
Multiline Retail
2 Outperform
4 Underperform
Automobiles
5 Outperform
0 Underperform
Air Freight and Logistics
5 Outperform
0 Underperform
Health/Biotechnology Funds
4 Outperform
0 Underperform
Aerospace and Defense
4 Outperform
0 Underperform
Personal Products
2 Outperform
2 Underperform
Paper and Forest Products
2 Outperform
1 Underperform
Trading Companies and Distributors
3 Outperform
0 Underperform
Office Electronics
1 Outperform
0 Underperform











RSS Headlines
Fool UK